What does high free T3 mean?

High free T3 levels indicate excess active thyroid hormone in your blood, often signaling hyperthyroidism or other thyroid conditions. This can cause symptoms like rapid heartbeat, weight loss, anxiety, and requires medical evaluation to determine the underlying cause and appropriate treatment.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Free T3 and Its Role in Your Body

Free T3 (triiodothyronine) is the active form of thyroid hormone that circulates unbound in your bloodstream. Unlike total T3, which includes both bound and unbound hormone, free T3 represents the portion readily available for your cells to use. This hormone plays a crucial role in regulating your metabolism, heart rate, body temperature, and energy production.

Your thyroid gland produces mainly T4 (thyroxine), which is then converted to the more active T3 form in various tissues throughout your body. While T4 acts as a storage form, T3 is approximately four times more potent and responsible for most thyroid hormone effects. Understanding your free T3 levels provides valuable insight into your thyroid function and overall metabolic health.

Normal Free T3 Ranges

Normal free T3 levels typically range from 2.3 to 4.2 pg/mL (picograms per milliliter), though reference ranges can vary slightly between laboratories. These values represent the optimal range where your metabolism functions efficiently without being overactive or sluggish.

Free T3 Reference Ranges and Clinical Interpretation

Free T3 LevelInterpretationClinical SignificanceCommon Causes
Below 2.3 pg/mL<2.3 pg/mLLowHypothyroidism or low T3 syndromeHashimoto's, medication effects, severe illness
2.3-4.2 pg/mL2.3-4.2 pg/mLNormalOptimal thyroid functionHealthy thyroid state
4.3-5.0 pg/mL4.3-5.0 pg/mLMildly elevatedSubclinical hyperthyroidism possibleEarly Graves', nodules, overmedication
Above 5.0 pg/mL>5.0 pg/mLSignificantly elevatedOvert hyperthyroidism likelyGraves' disease, toxic adenoma, thyroiditis

Reference ranges may vary by laboratory. Results should be interpreted alongside TSH and free T4 levels.

How Free T3 Differs from Total T3 and T4

While total T3 measures all triiodothyronine in your blood (both bound and unbound), free T3 specifically measures the unbound, biologically active portion. This distinction matters because only free hormones can enter cells and exert their effects. Similarly, free T4 represents unbound thyroxine, which serves as the precursor to T3. Testing free hormone levels often provides a more accurate picture of thyroid function than total hormone measurements.

Common Causes of High Free T3

Elevated free T3 levels can result from various conditions affecting thyroid function. Understanding these causes helps determine the appropriate treatment approach and management strategy.

Hyperthyroidism and Graves' Disease

Hyperthyroidism, particularly Graves' disease, represents the most common cause of elevated free T3. In Graves' disease, antibodies stimulate the thyroid gland to produce excess hormones. This autoimmune condition affects approximately 1 in 200 people and often runs in families. The overactive thyroid produces both excess T4 and T3, leading to elevated free hormone levels and characteristic symptoms.

Thyroid Nodules and Toxic Adenomas

Autonomous thyroid nodules, also called toxic adenomas, can produce thyroid hormones independently of normal regulatory mechanisms. These benign growths bypass the body's feedback systems, continuously releasing T3 and T4. Multiple functioning nodules, known as toxic multinodular goiter, can similarly cause elevated free T3 levels. Regular monitoring of your thyroid hormones can help detect these conditions early.

Thyroiditis and Medication Effects

Thyroiditis, or inflammation of the thyroid gland, can temporarily release stored hormones into the bloodstream, causing transient elevations in free T3. This can occur with subacute thyroiditis (often following a viral infection), postpartum thyroiditis, or silent thyroiditis. Additionally, taking too much thyroid hormone replacement medication or certain other drugs like amiodarone can elevate free T3 levels.

Symptoms of Elevated Free T3

High free T3 levels accelerate your metabolism and affect multiple body systems, leading to a constellation of symptoms that can significantly impact daily life. Recognizing these symptoms early enables prompt diagnosis and treatment.

  • Rapid or irregular heartbeat (palpitations)
  • Unexplained weight loss despite increased appetite
  • Heat intolerance and excessive sweating
  • Tremors, particularly in the hands
  • Anxiety, irritability, and mood swings
  • Difficulty sleeping or insomnia
  • Frequent bowel movements or diarrhea
  • Muscle weakness, especially in the upper arms and thighs
  • Thinning hair and brittle nails
  • Bulging eyes (in Graves' disease)
  • Irregular menstrual periods in women
  • Enlarged thyroid gland (goiter)

The severity and combination of symptoms vary among individuals. Some people experience subtle changes, while others develop pronounced symptoms affecting their quality of life. Older adults may present with fewer classic symptoms, sometimes showing only weight loss, weakness, or heart problems.

Health Risks of Untreated High Free T3

Persistently elevated free T3 levels pose serious health risks if left untreated. The continuous metabolic overdrive strains multiple organ systems, potentially leading to long-term complications.

Cardiovascular Complications

High free T3 levels significantly impact cardiovascular health. The excess hormone increases heart rate, cardiac output, and oxygen demand while potentially causing arrhythmias like atrial fibrillation. Over time, this can lead to heart failure, particularly in older adults or those with pre-existing heart conditions. Studies show that even subclinical hyperthyroidism increases cardiovascular mortality risk by 24-41%.

Bone Health and Osteoporosis

Chronic thyroid hormone excess accelerates bone turnover, leading to decreased bone density and increased fracture risk. Postmenopausal women face particularly high risk, with studies showing up to 12% bone loss over 2 years of untreated hyperthyroidism. This bone loss may not fully reverse even after treatment, emphasizing the importance of early intervention.

Thyroid Storm Risk

Though rare, thyroid storm represents a life-threatening complication of severe hyperthyroidism. This medical emergency involves extreme elevation of thyroid hormones, causing fever, rapid heart rate, delirium, and potentially organ failure. Triggers include infection, surgery, trauma, or discontinuing antithyroid medications. Immediate medical attention is crucial for survival.

Diagnostic Approach to High Free T3

Accurate diagnosis of elevated free T3 requires comprehensive thyroid function testing and clinical evaluation. A systematic approach helps identify the underlying cause and guide treatment decisions.

Complete Thyroid Panel Testing

Diagnosing thyroid dysfunction requires more than just TSH testing. A complete thyroid panel includes TSH, free T4, free T3, and often thyroid antibodies (TPOAb, TSI, or TRAb). This comprehensive approach reveals the full picture of thyroid function. For example, in early hyperthyroidism, TSH may be suppressed while free T3 remains normal, or in T3 toxicosis, only free T3 is elevated while free T4 stays normal.

Additional Testing and Imaging

Beyond blood tests, your healthcare provider may recommend thyroid ultrasound to evaluate gland structure and identify nodules. Radioactive iodine uptake scans help differentiate between various causes of hyperthyroidism. In Graves' disease, the uptake is diffusely increased, while in thyroiditis, it's typically low. These imaging studies, combined with clinical presentation and laboratory results, enable accurate diagnosis.

Treatment Options for Elevated Free T3

Treatment for high free T3 depends on the underlying cause, symptom severity, and individual factors like age and pregnancy status. The goal is normalizing thyroid hormone levels while minimizing side effects and preventing recurrence.

Antithyroid Medications

Methimazole and propylthiouracil (PTU) are the primary medications for reducing thyroid hormone production. Methimazole is generally preferred due to its once-daily dosing and lower risk of severe side effects. These medications work by blocking thyroid peroxidase, the enzyme responsible for hormone synthesis. Treatment typically continues for 12-18 months, with regular monitoring to adjust dosing and watch for side effects like liver dysfunction or low white blood cell count.

Radioactive Iodine and Surgery

For definitive treatment, radioactive iodine therapy destroys overactive thyroid tissue. This outpatient procedure is highly effective but often results in hypothyroidism requiring lifelong hormone replacement. Surgical removal of all or part of the thyroid (thyroidectomy) offers immediate results but carries surgical risks and also typically leads to hypothyroidism. The choice between these options depends on factors like goiter size, patient preference, and contraindications.

Beta Blockers and Supportive Care

Beta blockers like propranolol provide rapid symptom relief by blocking thyroid hormone effects on the heart and nervous system. While they don't lower hormone levels, they effectively control palpitations, tremors, and anxiety. Additional supportive measures include adequate nutrition, stress management, and avoiding iodine-rich foods or supplements that could worsen hyperthyroidism.

Monitoring and Long-term Management

Successfully managing elevated free T3 requires ongoing monitoring and adjustment of treatment strategies. Regular testing ensures hormone levels remain within target ranges while watching for potential complications or recurrence.

Follow-up Testing Schedule

During initial treatment, thyroid function tests are typically performed every 4-6 weeks until levels stabilize. Once euthyroid (normal thyroid function) is achieved, testing frequency decreases to every 3-6 months. Long-term monitoring continues indefinitely, as hyperthyroidism can recur, especially in Graves' disease where remission rates vary from 30-50%. Regular testing helps detect changes early, allowing prompt treatment adjustments.

Lifestyle Modifications

Supporting thyroid health through lifestyle changes complements medical treatment. Stress reduction techniques like meditation or yoga help manage symptoms and may improve treatment outcomes. Regular exercise, once symptoms are controlled, supports cardiovascular health and bone density. Adequate calcium and vitamin D intake becomes especially important given the increased osteoporosis risk. Avoiding excessive iodine from supplements or iodine-rich foods prevents exacerbating hyperthyroidism.

Taking Control of Your Thyroid Health

High free T3 levels signal an overactive thyroid requiring prompt attention and appropriate treatment. While the diagnosis may feel overwhelming, modern medicine offers effective treatments that can restore normal thyroid function and eliminate symptoms. The key lies in early detection through comprehensive testing, working closely with healthcare providers to find the right treatment approach, and maintaining long-term monitoring to ensure continued health.

Remember that thyroid conditions are highly treatable, and most people with hyperthyroidism go on to live normal, healthy lives with proper management. Whether through medication, radioactive iodine, or surgery, treatment options exist to suit individual needs and preferences. By staying informed about your condition, adhering to treatment plans, and maintaining regular follow-up care, you can successfully manage elevated free T3 and protect your long-term health.

References

  1. Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., ... & Walter, M. A. (2016). 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid, 26(10), 1343-1421.[PubMed][DOI]
  2. De Leo, S., Lee, S. Y., & Braverman, L. E. (2016). Hyperthyroidism. The Lancet, 388(10047), 906-918.[PubMed][DOI]
  3. Biondi, B., & Cooper, D. S. (2018). Subclinical hyperthyroidism. New England Journal of Medicine, 378(25), 2411-2419.[PubMed][DOI]
  4. Kahaly, G. J., Bartalena, L., Hegedüs, L., Leenhardt, L., Poppe, K., & Pearce, S. H. (2018). 2018 European Thyroid Association guideline for the management of Graves' hyperthyroidism. European Thyroid Journal, 7(4), 167-186.[PubMed][DOI]
  5. Boelaert, K., Torlinska, B., Holder, R. L., & Franklyn, J. A. (2010). Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study. The Journal of Clinical Endocrinology & Metabolism, 95(6), 2715-2726.[PubMed][DOI]
  6. Selmer, C., Olesen, J. B., Hansen, M. L., von Kappelgaard, L. M., Madsen, J. C., Hansen, P. R., ... & Torp-Pedersen, C. (2014). Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. The Journal of Clinical Endocrinology & Metabolism, 99(7), 2372-2382.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my free T3 at home?

You can test your free T3 at home with SiPhox Health's Core Health Program by adding the Thyroid+ expansion, which includes Free T3, Free T4, and TPOAb testing. The Ultimate 360 Health Program includes comprehensive thyroid testing with Free T3, Free T4, TSH, and TPOAb in the base panel.

What is the difference between high free T3 and high total T3?

Free T3 measures only the unbound, active hormone available to enter cells, while total T3 includes both bound and unbound hormone. High free T3 is more clinically significant as it represents the biologically active portion affecting your metabolism. Some conditions can cause discordance between free and total levels due to changes in binding proteins.

Can stress cause elevated free T3 levels?

While acute stress typically doesn't directly elevate free T3, chronic stress can affect thyroid function through various mechanisms. Stress may worsen existing hyperthyroidism symptoms or trigger thyroid storm in severe cases. However, stress alone rarely causes primary elevation of free T3 without underlying thyroid disease.

How long does it take to normalize high free T3 levels with treatment?

With antithyroid medications, free T3 levels typically begin improving within 2-4 weeks, though full normalization may take 6-12 weeks. Beta blockers provide symptom relief within hours to days. The timeline varies based on the initial severity, underlying cause, and individual response to treatment. Regular monitoring ensures appropriate dose adjustments.

What foods should I avoid with high free T3?

Limit iodine-rich foods like seaweed, kelp, and iodized salt, as excess iodine can worsen hyperthyroidism. Avoid caffeine and alcohol which may intensify symptoms like palpitations and anxiety. Some practitioners recommend limiting soy products as they may interfere with thyroid hormone absorption if you're taking medications.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details